139 related articles for article (PubMed ID: 12085185)
1. Expression of cdc25A and cdc25B proteins in thyroid neoplasms.
Ito Y; Yoshida H; Nakano K; Kobayashi K; Yokozawa T; Hirai K; Matsuzuka F; Matsuura N; Kakudo K; Kuma K; Miyauchi A
Br J Cancer; 2002 Jun; 86(12):1909-13. PubMed ID: 12085185
[TBL] [Abstract][Full Text] [Related]
2. Expression of cdc25B and cdc25A in medullary thyroid carcinoma: cdc25B expression level predicts a poor prognosis.
Ito Y; Yoshida H; Tomoda C; Uruno T; Takamura Y; Miya A; Kobayashi K; Matsuzuka F; Kuma K; Nakamura Y; Kakudo K; Miyauchi A
Cancer Lett; 2005 Nov; 229(2):291-7. PubMed ID: 16095809
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of human tumor-associated antigen, RCAS1, is significantly linked to dedifferentiation of thyroid carcinoma.
Ito Y; Yoshida H; Nakano K; Kobayashi K; Yokozawa T; Hirai K; Matsuzuka F; Matsuura N; Kuma K; Miyauchi A
Oncology; 2003; 64(1):83-9. PubMed ID: 12457035
[TBL] [Abstract][Full Text] [Related]
4. Cdc25A and cdc25B expression in malignant lymphoma of the thyroid: correlation with histological subtypes and cell proliferation.
Ito Y; Yoshida H; Matsuzuka F; Matsuura N; Nakamura Y; Nakamine H; Kakudo K; Kuma K; Miyauchi A
Int J Mol Med; 2004 Mar; 13(3):431-5. PubMed ID: 14767575
[TBL] [Abstract][Full Text] [Related]
5. Expression and cellular localization of p8 protein in thyroid neoplasms.
Ito Y; Yoshida H; Motoo Y; Miyoshi E; Iovanna JL; Tomoda C; Uruno T; Takamura Y; Miya A; Kobayashi K; Matsuzuka F; Matsuura N; Kuma K; Miyauchi A
Cancer Lett; 2003 Nov; 201(2):237-44. PubMed ID: 14607339
[TBL] [Abstract][Full Text] [Related]
6. p130 expression in thyroid neoplasms: its linkage with tumor size and dedifferentiation.
Ito Y; Yoshida H; Uruno T; Nakano K; Takamura Y; Miya A; Kobayashi K; Yokozawa T; Matsuzuka F; Kuma K; Miyauchi A
Cancer Lett; 2003 Mar; 192(1):83-7. PubMed ID: 12637156
[TBL] [Abstract][Full Text] [Related]
7. Clinical significance of CDC25A and CDC25B expression in squamous cell carcinomas of the oesophagus.
Nishioka K; Doki Y; Shiozaki H; Yamamoto H; Tamura S; Yasuda T; Fujiwara Y; Yano M; Miyata H; Kishi K; Nakagawa H; Shamma A; Monden M
Br J Cancer; 2001 Aug; 85(3):412-21. PubMed ID: 11487274
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of cdc25A and cdc25B is frequent in primary non-small cell lung cancer but is not associated with overexpression of c-myc.
Wu W; Fan YH; Kemp BL; Walsh G; Mao L
Cancer Res; 1998 Sep; 58(18):4082-5. PubMed ID: 9751615
[TBL] [Abstract][Full Text] [Related]
9. Expression of cdc25A and cdc25B phosphatase in breast carcinoma.
Ito Y; Yoshida H; Uruno T; Takamura Y; Miya A; Kuma K; Miyauchi A
Breast Cancer; 2004; 11(3):295-300. PubMed ID: 15550849
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of CDC25A and CDC25B in head and neck cancers.
Gasparotto D; Maestro R; Piccinin S; Vukosavljevic T; Barzan L; Sulfaro S; Boiocchi M
Cancer Res; 1997 Jun; 57(12):2366-8. PubMed ID: 9192810
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of CDC25A phosphatase is associated with hypergrowth activity and poor prognosis of human hepatocellular carcinomas.
Xu X; Yamamoto H; Sakon M; Yasui M; Ngan CY; Fukunaga H; Morita T; Ogawa M; Nagano H; Nakamori S; Sekimoto M; Matsuura N; Monden M
Clin Cancer Res; 2003 May; 9(5):1764-72. PubMed ID: 12738732
[TBL] [Abstract][Full Text] [Related]
12. Induction of the adenoma-carcinoma progression and Cdc25A-B phosphatases by the trefoil factor TFF1 in human colon epithelial cells.
Rodrigues S; Rodrigue CM; Attoub S; Fléjou JF; Bruyneel E; Bracke M; Emami S; Gespach C
Oncogene; 2006 Oct; 25(50):6628-36. PubMed ID: 16715141
[TBL] [Abstract][Full Text] [Related]
13. S100A9 expression is significantly linked to dedifferentiation of thyroid carcinoma.
Ito Y; Arai K; Ryushi ; Nozawa ; Yoshida H; Tomoda C; Uruno T; Miya A; Kobayashi K; Matsuzuka F; Kuma K; Kakudo K; Miyauchi A
Pathol Res Pract; 2005; 201(8-9):551-6. PubMed ID: 16259107
[TBL] [Abstract][Full Text] [Related]
14. Decreased expression of p107 is correlated with anaplastic transformation in papillary carcinoma of the thyroid.
Ito Y; Yoshida H; Tomoda C; Uruno T; Takamura Y; Miya A; Kobayashi K; Matsuzuka F; Kuma K; Miyauchi A
Anticancer Res; 2003; 23(5A):3819-24. PubMed ID: 14666683
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical analysis of p27/kip1 expression in thyroid carcinoma.
Resnick MB; Schacter P; Finkelstein Y; Kellner Y; Cohen O
Mod Pathol; 1998 Aug; 11(8):735-9. PubMed ID: 9720501
[TBL] [Abstract][Full Text] [Related]
16. Delta Np73 expression in thyroid neoplasms originating from follicular cells.
Ito Y; Uramoto H; Funa K; Yoshida H; Jikuzono T; Asahi S; Higashiyama T; Tomoda C; Takamura Y; Miya A; Kobayashi K; Matsuzuka F; Kuma K; Miyauchi A
Pathology; 2006 Jun; 38(3):205-9. PubMed ID: 16753740
[TBL] [Abstract][Full Text] [Related]
17. High level of tumour protein p53-induced nuclear protein 1 (TP53INP1) expression in anaplastic carcinoma of the thyroid.
Ito Y; Motoo Y; Yoshida H; Iovanna JL; Nakamura Y; Kuma K; Miyauchi A
Pathology; 2006 Dec; 38(6):545-7. PubMed ID: 17393983
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of CDC25B, CDC25C and phospho-CDC25C (Ser216) in vulvar squamous cell carcinomas are associated with malignant features and aggressive cancer phenotypes.
Wang Z; Trope CG; Flørenes VA; Suo Z; Nesland JM; Holm R
BMC Cancer; 2010 May; 10():233. PubMed ID: 20500813
[TBL] [Abstract][Full Text] [Related]
19. Apolipoprotein e expression in anaplastic thyroid carcinoma.
Ito Y; Takano T; Miyauchi A
Oncology; 2006; 71(5-6):388-93. PubMed ID: 17690558
[TBL] [Abstract][Full Text] [Related]
20. The expression and role of serum response factor in papillary carcinoma of the thyroid.
Kim HJ; Kim KR; Park HS; Jang KY; Chung MJ; Shong M; Moon WS
Int J Oncol; 2009 Jul; 35(1):49-55. PubMed ID: 19513551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
